Mohammad Hossein Baradaranfar

Mohammad Hossein Baradaranfar

Auto-generated profile, based on publicly available information

Mohammad Hossein Baradaranfar

Department of Otolaryngology-Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
HBHojat Bahmanzadeh
Hojat Bahmanzadeh
OAOmid Abouali
Omid Abouali
MFMohammad Faramarzi
Mohammad Faramarzi
Goodarz AhmadiGoodarz Ahmadi
Goodarz Ahmadi

24 January 2013 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
SASaeid Atighechi
Saeid Atighechi
MAMohammad Reza Azimi
Mohammad Reza Azimi
SMSeyyed Abbas Mirvakili
Seyyed Abbas Mirvakili
MBMohammad Hossein Baradaranfar
Mohammad Hossein Baradaranfar
MDMohammad Hossein Dadgarnia
Mohammad Hossein Dadgarnia

20 December 2008 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
SASaeid Atighechi
Saeid Atighechi
MBMohammad Hossein Baradaranfar
Mohammad Hossein Baradaranfar
GKGhasem Karimi
Ghasem Karimi
RJRozita Jafari
Rozita Jafari

1 November 2006 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
PBPeyman Borghei
Peyman Borghei
MBMohammad Hossein Baradaranfar
Mohammad Hossein Baradaranfar
SBSeyed Hebatodin Borghei
Seyed Hebatodin Borghei
FSFarnoosh Sokhandon
Farnoosh Sokhandon
Juvenile nasopharyngeal angiofibroma (JNA) is a benign, highly vascular, and locally invasive tumor. Because the location of these tumors makes conventional surgery difficult, interest in endoscopic resection is increasing, particularly for the treatment of lesions that do not extend laterally into the infratemporal fossa. We report the results of our series of 23 patients with JNA (stage IIB or lower) who underwent transnasal endoscopic resection under hypotensive general anesthesia without preoperative embolization of the tumor. All tumors were successfully excised. The amount of intraoperative blood loss was acceptable. We observed only 1 recurrence, which was diagnosed 19 months postoperatively in a patient with a stage IIB primary tumor. We observed only 3 complications during follow-up—all synechia. We conclude that endoscopic resection of JNAs is safe and effective. The low incidence of recurrence and complications in this series indicates that preoperative embolization may not be necessary for lesions that have not undergone extensive spread; instead, intraoperative bleeding can be adequately controlled with good hypotensive general anesthesia.

1 March 2014 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
MBMohammad Hossein Bardaranfar
Mohammad Hossein Bardaranfar
ZRZahra Ranjbar
Zahra Ranjbar
MDMohammad Hossein Dadgarnia
Mohammad Hossein Dadgarnia
SASaeid Atighechi
Saeid Atighechi
AMAbbas Mirvakili
Abbas Mirvakili
ABAmin Baradaranfar
Amin Baradaranfar
Background: Chronic rhinosinusitis (CRS) is an inflammatory process that causes different clinical symptoms: nasal blockage and congestion, posterior and anterior nasal drip, and smell disorder ranging from reduced olfaction (hyposmia) to complete loss of smell (anosmia). It has been suggested that mechanical blockage of olfactory clef after polypectomy is responsible for the persistent impairment of olfaction in some cases. The aim of this study was to evaluate the efficacy of application of steroids at the olfactory cleft in improving olfactory function in patients who underwent sinus surgery. Methods: A double-blind, randomized controlled trial was conducted in Yazd, Iran, between March and December 2012. Eligible patients who had CRS with polyposis and underwent functional endoscopic sinus surgery were recruited. An absorbable gelatin dressing combined with triamcinolone (case) or normal saline (control) was applied at the site of surgery. Olfaction was assessed by butanol threshold tests before and 8 weeks after surgery. Results: A total of 60 patients were enrolled into the study and were equally divided into triamcinolone and control groups. Subjects in both arms of trial experienced augmentation of smell function throughout the study; however, patients who received triamcinolone had better improvement after 8 weeks (p = 0.007). Complete remission rate was 100% in the triamcinolone group and the corresponding figure was 76% in the control group. Conclusion: We suggest that application of triamcinolone at the olfactory cleft can boost the effect of surgery in restoring olfactory function.

17 July 2019 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
MSMahmood Shishegar
Mahmood Shishegar
MFMohammad Faramarzi
Mohammad Faramarzi
MRMohsen Rashidi Ravari
Mohsen Rashidi Ravari